Pharmacovigilance Notice

No information relating to the safety of Bristol-Myers Squibb products will be provided on this website. Furthermore, this website was not designed for the purpose of collecting information on the safety of Bristol-Myers Squibb products. If you would like to report an adverse event, pregnancy, overdose or unexpected therapeutic effect that has occurred with a patient, please contact Bristol-Myers Squibb's Pharmacovigilance Department directly.

Contact:
Email: medicalinfo.belgium@bms.com
Phone: